NCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
Clinical Trials
13 trialsNCT01588990 2019-01-22
ASCENT
Hoffmann-La Roche
Phase 4 Completed
NCT00812864 2018-08-28
capagec
University Hospital, Limoges
Phase 4 Completed
NCT02248571 2017-11-13
IMPROVE
iOMEDICO AG
Phase 4 Completed
NCT02567331 2016-11-02
A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT02581423 2016-11-02
A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT01641458 2016-02-02
FLOXTOX2
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT00502671 2015-09-03
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
Hoffmann-La Roche
Phase 4 Completed
NCT00577031 2015-08-18
OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
Hoffmann-La Roche
Phase 4 Completed
NCT00127933 2011-08-10
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00559676 2011-05-16
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 4 Completed
NCT00121836 2011-04-27
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00220168 2009-12-16
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Royal Marsden NHS Foundation Trust
Phase 4 Completed